Cargando…

Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component

Ovarian cancer ranks seventh in the most common malignant tumors among female disease, which seriously threatens female reproductive health. It is characterized by hidden pathogenesis, missed diagnosis, high reoccurrence rate, and poor prognosis. In clinic, the first-line treatment prioritized debul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jingyuan, Zhou, Tuoyu, Wang, Yinxue, Jiang, Yanbiao, Wang, Yiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512305/
https://www.ncbi.nlm.nih.gov/pubmed/34641493
http://dx.doi.org/10.3390/molecules26195949
_version_ 1784582958928101376
author Wu, Jingyuan
Zhou, Tuoyu
Wang, Yinxue
Jiang, Yanbiao
Wang, Yiqing
author_facet Wu, Jingyuan
Zhou, Tuoyu
Wang, Yinxue
Jiang, Yanbiao
Wang, Yiqing
author_sort Wu, Jingyuan
collection PubMed
description Ovarian cancer ranks seventh in the most common malignant tumors among female disease, which seriously threatens female reproductive health. It is characterized by hidden pathogenesis, missed diagnosis, high reoccurrence rate, and poor prognosis. In clinic, the first-line treatment prioritized debulking surgery with paclitaxel-based chemotherapy. The harsh truth is that female patients are prone to relapse due to the dissemination of tumor cells and drug resistance. In these circumstances, the development of new therapy strategies combined with traditional approaches is conductive to improving the quality of treatment. Among numerous drug resources, botanical compounds have unique advantages due to their potentials in multitarget functions, long application history, and wide availability. Previous studies have revealed the therapeutic effects of bioactive plant components in ovarian cancer. These natural ingredients act as part of the initial treatment or an auxiliary option for maintenance therapy, further reducing the tumor and metastatic burden. In this review, we summarized the functions and mechanisms of natural botanical components applied in human ovarian cancer. We focused on the molecular mechanisms of cell apoptosis, autophagy, RNA and DNA lesion, ROS damage, and the multiple-drug resistance. We aim to provide a theoretical reference for in-depth drug research so as to manage ovarian cancer better in clinic.
format Online
Article
Text
id pubmed-8512305
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85123052021-10-14 Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component Wu, Jingyuan Zhou, Tuoyu Wang, Yinxue Jiang, Yanbiao Wang, Yiqing Molecules Review Ovarian cancer ranks seventh in the most common malignant tumors among female disease, which seriously threatens female reproductive health. It is characterized by hidden pathogenesis, missed diagnosis, high reoccurrence rate, and poor prognosis. In clinic, the first-line treatment prioritized debulking surgery with paclitaxel-based chemotherapy. The harsh truth is that female patients are prone to relapse due to the dissemination of tumor cells and drug resistance. In these circumstances, the development of new therapy strategies combined with traditional approaches is conductive to improving the quality of treatment. Among numerous drug resources, botanical compounds have unique advantages due to their potentials in multitarget functions, long application history, and wide availability. Previous studies have revealed the therapeutic effects of bioactive plant components in ovarian cancer. These natural ingredients act as part of the initial treatment or an auxiliary option for maintenance therapy, further reducing the tumor and metastatic burden. In this review, we summarized the functions and mechanisms of natural botanical components applied in human ovarian cancer. We focused on the molecular mechanisms of cell apoptosis, autophagy, RNA and DNA lesion, ROS damage, and the multiple-drug resistance. We aim to provide a theoretical reference for in-depth drug research so as to manage ovarian cancer better in clinic. MDPI 2021-09-30 /pmc/articles/PMC8512305/ /pubmed/34641493 http://dx.doi.org/10.3390/molecules26195949 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wu, Jingyuan
Zhou, Tuoyu
Wang, Yinxue
Jiang, Yanbiao
Wang, Yiqing
Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title_full Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title_fullStr Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title_full_unstemmed Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title_short Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
title_sort mechanisms and advances in anti-ovarian cancer with natural plants component
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512305/
https://www.ncbi.nlm.nih.gov/pubmed/34641493
http://dx.doi.org/10.3390/molecules26195949
work_keys_str_mv AT wujingyuan mechanismsandadvancesinantiovariancancerwithnaturalplantscomponent
AT zhoutuoyu mechanismsandadvancesinantiovariancancerwithnaturalplantscomponent
AT wangyinxue mechanismsandadvancesinantiovariancancerwithnaturalplantscomponent
AT jiangyanbiao mechanismsandadvancesinantiovariancancerwithnaturalplantscomponent
AT wangyiqing mechanismsandadvancesinantiovariancancerwithnaturalplantscomponent